OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward clinically applicable biomarkers for asthma: An EAACI position paper
Zuzana Diamant, Susanne J. H. Vijverberg, Kjell Alving, et al.
Allergy (2019) Vol. 74, Iss. 10, pp. 1835-1851
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

EUFOREA consensus on biologics for CRSwNP with or without asthma
Wytske J. Fokkens, Valerie J. Lund, Claus Bachert, et al.
Allergy (2019) Vol. 74, Iss. 12, pp. 2312-2319
Open Access | Times Cited: 314

Allergic Endotypes and Phenotypes of Asthma
Nicole Akar-Ghibril, Thomas B. Casale, Adnan Ćustović, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 2, pp. 429-440
Open Access | Times Cited: 228

EAACI Biologicals Guidelines—Recommendations for severe asthma
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 14-44
Open Access | Times Cited: 219

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 198

Advances and highlights in biomarkers of allergic diseases
İsmail Öğülür, Yağız Pat, Özge Ardıçlı, et al.
Allergy (2021) Vol. 76, Iss. 12, pp. 3659-3686
Open Access | Times Cited: 150

Advances and recent developments in asthma in 2020
Lacin Cevhertas, İsmail Öğülür, Debbie J. Maurer, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3124-3146
Open Access | Times Cited: 149

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline
Sumita Khatri, Jonathan M. Iaccarino, Amisha V. Barochia, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 204, Iss. 10, pp. e97-e109
Open Access | Times Cited: 107

GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases
Michela Abrami, Alice Biasin, Fabiana Tescione, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1933-1933
Open Access | Times Cited: 21

Perspectives in allergen immunotherapy: 2019 and beyond
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 130

Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs
Inmaculada Doña, Natalia Pérez‐Sánchez, Ibón Eguíluz-Gracia, et al.
Allergy (2019) Vol. 75, Iss. 3, pp. 561-575
Open Access | Times Cited: 102

Severe Eosinophilic Asthma
Agamemnon Bakakos, Stelios Loukides, Petros Bakakos
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 98

The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020
Hans‐Uwe Simon, Shída Yousefi, Nina Germič, et al.
International Archives of Allergy and Immunology (2019) Vol. 181, Iss. 1, pp. 11-23
Open Access | Times Cited: 93

T2-high asthma phenotypes across lifespan
Nicole Maison, Jimmy Omony, Sabina Illi, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 3, pp. 2102288-2102288
Open Access | Times Cited: 49

Current unmet needs and potential solutions to uncontrolled asthma
William W. Busse, Monica Kraft
European Respiratory Review (2022) Vol. 31, Iss. 163, pp. 210176-210176
Open Access | Times Cited: 43

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Ilja Střı́ž, Korneliusz Golebski, Zuzana Střížová, et al.
Clinical Science (2023) Vol. 137, Iss. 9, pp. 727-753
Open Access | Times Cited: 33

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
Linda Rogers, Miloš Jeseňák, Leif Bjermer, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107414-107414
Open Access | Times Cited: 25

Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2518-2518
Open Access | Times Cited: 24

Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
Paola Maria Cutroneo, Elena Arzenton, Fabiana Furci, et al.
BioDrugs (2024) Vol. 38, Iss. 3, pp. 425-448
Open Access | Times Cited: 11

Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Celeste Porsbjerg, Jonathan N. Townend, Céline Bergeron, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

Urinary Leukotriene E₄and Prostaglandin D₂Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
Johan Kolmert, Cristina Gómez, David Balgoma, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 37-53
Open Access | Times Cited: 66

Severe asthma phenotypes and endotypes
Ioana Agache
Seminars in Immunology (2019) Vol. 46, pp. 101301-101301
Closed Access | Times Cited: 60

Uncontrolled Asthma: Unmet Needs in the Management of Patients
Marco Caminati, Rachele Vaia, Fabiana Furci, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 457-466
Open Access | Times Cited: 48

Biomarcadores biológicos en las enfermedades respiratorias
Francisco García‐Río, Bernardino Alcázar Navarrete, Diego Castillo, et al.
Archivos de Bronconeumología (2022) Vol. 58, Iss. 4, pp. 323-333
Closed Access | Times Cited: 30

Exploring the potential and safety of quantum dots in allergy diagnostics
Milad Mohkam, Mohammad Sadraeian, Antonio Lauto, et al.
Microsystems & Nanoengineering (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22

Page 1 - Next Page

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 1-25 of 161 citing articles:

Your Privacy